Baohui Liu

ORCID: 0000-0001-5821-6945
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • Ferroptosis and cancer prognosis
  • Cancer-related molecular mechanisms research
  • RNA modifications and cancer
  • Autophagy in Disease and Therapy
  • MicroRNA in disease regulation
  • Bioinformatics and Genomic Networks
  • Single-cell and spatial transcriptomics
  • Cancer Mechanisms and Therapy
  • Circular RNAs in diseases
  • Cell death mechanisms and regulation
  • Cancer Cells and Metastasis
  • RNA Research and Splicing
  • Cancer-related Molecular Pathways
  • Epigenetics and DNA Methylation
  • Cancer Research and Treatments
  • Immunotherapy and Immune Responses
  • Medicinal Plant Pharmacodynamics Research
  • TGF-β signaling in diseases
  • Cancer, Hypoxia, and Metabolism
  • Neurogenesis and neuroplasticity mechanisms
  • PI3K/AKT/mTOR signaling in cancer
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Melanoma and MAPK Pathways
  • PARP inhibition in cancer therapy

Fujian Medical University
2025

Renmin Hospital of Wuhan University
2015-2024

Wuhan University
2015-2024

Binzhou University
2024

Binzhou Medical University
2024

Zhengzhou People's Hospital
2020

Shandong University
2020

Hubei Cancer Hospital
2019

Beijing Shijitan Hospital
2014

Capital Medical University
2014

Abstract Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor. The unregulated expression of Claudin-4 (CLDN4) plays an important role in tumor progression. However, biological CLDN4 GBM still unknown. This study aimed to determine whether mediates glioma progression, if so, it would further explore molecular mechanisms carcinogenesis. Our results revealed that was significantly upregulated specimens cells. inhibition CLND4 could inhibit mesenchymal...

10.1038/s41419-022-04788-8 article EN cc-by Cell Death and Disease 2022-04-13

Glioblastoma (GBM) is the most common and fatal primary tumor in central nervous system (CNS). Due to existence of blood-brain barrier (BBB), therapeutics cannot efficiently reach tumors brain, as a result, they are unable be used for effective GBM treatment. Accumulating evidence shows that delivery form nanoparticles (NPs) may allow crossing BBB

10.1186/s12951-022-01238-7 article EN cc-by Journal of Nanobiotechnology 2022-01-21

Abstract Background Glioblastoma (GBM) is the most common primary malignant tumor in central nervous system. Paclitaxel (PTX) a well‐established and highly effective anti‐cancer drug for peripheral solid tumors. However, application of PTX GBM hindered by several limitations, including poor water solubility, restricted entry across blood–brain barrier (BBB), enhanced excretion efflux transporters. P‐glycoprotein (P‐gp) crucial transporter that abundantly present cerebral vascular endothelial...

10.1111/cns.14528 article EN cc-by CNS Neuroscience & Therapeutics 2023-12-04

Accumulating evidence suggests that iron-associated proteins contribute to tumor initiation and development. Ferritin light chain (FTL), a key protein in iron metabolism, is associated with the survival of glioblastoma multiforme (GBM) patients; however, molecular mechanisms underlying this association remain largely unclear. Therefore, present study, we investigated role FTL pathogenesis GBM. By using quantitative real-time RT-PCR, found expression was higher patients GBM than those...

10.1371/journal.pone.0149361 article EN cc-by PLoS ONE 2016-02-12

Abstract Background Ferroptosis plays a key role in human cancer, but its function and mechanism glioma is not clear. P62/SQSTM1 was reported to inhibit ferroptosis via the activation of NRF2 signaling pathway. In this study we reveal dual p62 glioblastoma (GBM) according p53 status. Method Lipid peroxidation analysis, transmission electron microscopy (TEM), GSH assay were performed determine level ferroptosis. Western blot qPCR obtained detect expression markers. Construction mutant...

10.1186/s13578-022-00764-z article EN cc-by Cell & Bioscience 2022-02-25

Abstract Aims Circular RNAs have been reported to play key roles in the progression of various cancers, including gliomas. The present study was designed investigate role hsa_circ_0072309 autophagy and temozolomide (TMZ) sensitivity glioblastoma (GBM). Methods effect on TMZ were examined by GFP‐RFP‐LC3, transmission electron microscopy(TEM), flow cytometry, Western blot, immunofluorescence. mechanism regulating p53 signaling pathway analyzed using IP, rescue experiments. Results Low...

10.1111/cns.13821 article EN CNS Neuroscience & Therapeutics 2022-02-25

Circulating tumor cell (CTC) detection is a promising noninvasive technique that can be used to diagnose cancer, monitor progression, and predict prognosis. In this study, the authors aimed investigate clinical utility of CTCs in management diffuse glioma.

10.3171/2024.1.jns232020 article EN Journal of neurosurgery 2024-04-01

Radiotherapy (RT) continues to encounter significant obstacles such as formidable resistance, potential harm adjacent healthy cells, and restricted effectiveness against tumors, resulting in a notable recurrence rate. Therefore, combining imaging, other treatments, suitable enzyme activity one nanoplatform can enhance the RT effect reduce damage normal tissue. In this study, integrating hafnium Prussian blue (PB) nanoparticles (PB NPs) provided innovative hafnium-doped PB (HPB) NPs...

10.1021/acs.bioconjchem.5c00064 article EN Bioconjugate Chemistry 2025-03-07

Rho family guanosine triphosphatase (GTPase) 3 (Rnd3), a member of the small GTPase family, is involved in regulation cell actin cytoskeleton dynamics, migration, and proliferation through kinase-dependent signaling pathway. We report role Rnd3 pathogenesis hydrocephalus disorder. Mice with genetic deletion developed severe obstructive enlargement lateral third ventricles, but not fourth ventricles. The cerebral aqueducts Rnd3-null mice were partially or completely blocked by overgrowth...

10.1073/pnas.1219995110 article EN Proceedings of the National Academy of Sciences 2013-04-29

Glioblastoma multiforme, the most prevalent and aggressive brain tumour, has a poor prognosis. The molecular mechanisms underlying gliomagenesis remain poorly understood. Therefore, research, including various markers, is necessary to understand occurrence development of glioma. Weighted gene co-expression network analysis (WGCNA) was performed construct in TCGA glioblastoma samples. Gene ontology (GO) pathway-enrichment were used identify significance modules. Cox proportional hazards...

10.1186/s12920-018-0407-1 article EN cc-by BMC Medical Genomics 2018-11-01

Activation of Snail1 signaling promotes the migration and invasion multiple tumors, including glioblastoma multiforme (GBM). However, molecular mechanism that augments during GBM cell remains largely unknown. Identification factors regulate is critical to block tumor invasion. By screening human specimens, we found expression levels small GTPase RND3 positively correlated with E-cadherin claudin, biomarkers negatively regulated by Snail1. Downregulation claudin has been associated cells. We...

10.18632/oncotarget.12396 article EN Oncotarget 2016-10-01

Ferroptosis is an iron dependent cell death closely associated with p53 signaling pathway and aberrantly regulated in glioblastoma (GBM), yet the underlying mechanism needs more exploration. Identifying new factors which regulate ferroptosis GBM essential for treatment.Glioma growth was evaluated by viability assays colony formation assays. Lipid reactive oxygen species (ROS) assays, lipid peroxidation glutathione transmission electron microscopy were used to assess degree of cellular GBM....

10.1186/s13578-022-00791-w article EN cc-by Cell & Bioscience 2022-05-03

The Fc Fragment of IgG Binding Protein (FCGBP) has been proven to participate in intestinal tumor immunity. However, the biological role FCGBP remained unclear glioma. differential expression was explored by Oncomine and GEPIA databases. effect on prognosis analyzed via Kaplan–Meier plotter GEPIA. Tumor Immune Estimation Resource (TIMER) tool used determine correlations with immune infiltration. Firstly, highly expressed glioma correlated a worse prognosis. Gene Ontology (GO) KEGG pathway...

10.3389/fonc.2021.769033 article EN cc-by Frontiers in Oncology 2022-01-03

The aim of this study was to analyse 19 recurrent keratocystic odontogenic tumours (KCOTs).19 patients with KCOTs were retrospectively analysed. These had been treated by either enucleation or a combination and Carnoy's solution. analyses covered major aspects primary KCOT and/or identities, including patient profile, clinical features, histopathology, radiology, treatment prognosis.19 (7.4%) out 257 cases recurred, an average age 30.5 years (age range 18-45 years). 15 lesions in the...

10.1259/dmfr/22891281 article EN Dentomaxillofacial Radiology 2012-02-01

PURPOSE: To investigate the anticancer activity of ellagic acid (EA) in U251 human glioblastoma cells and its possible molecular mechanism. METHODS: The were treated with EA at various concentrations for different time periods. Cell viability cell proliferation detected by counting kit-8(CCK-8) assay live/dead respectively. apoptosis measured Annexin V-FITC/PI double staining method flow cytometry Mitochondrial membrane potential separately. cycle was PI cytometry. expressions Bcl-2,...

10.1590/s0102-865020160020000010 article EN cc-by Acta Cirúrgica Brasileira 2016-02-01

Glioblastoma is the most common type of primary brain tumour in adults, and its pathogenesis particularly complicated. Among many possible mechanisms underlying pathogenesis, hyperactivation PI3K/Akt pathway essential to occurrence development glioma through loss PTEN or somatic activating mutations PIK3CA. In present study, we investigated effect PI3Kβ inhibitor AZD6482 on cells. The CCK-8 assay showed dose-dependent cytotoxicity cell lines treated with AZD6482. Additionally, treatment was...

10.3892/or.2018.6845 article EN cc-by-nc-nd Oncology Reports 2018-11-02
Coming Soon ...